Evidence for clinical strategies in inoperable HCC with PVTT.



Worldwide, hepatocellular carcinoma (HCC) was the seventh most commonly diagnosed malignancy and the third leading cause of cancer-related death in 2020 [1]. Portal vein tumour thrombus (PVTT), regarded as the most usual form of vascular invasion in liver cancer, is observed in 10–60% of HCC patients

Copyright © 2020 Terumo India Private limited

X
Important information regarding

By using this website, you consent to the use of cookies in accordance with our